Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck

This page shows the latest Lundbeck news and features for those working in and with pharma, biotech and healthcare.

AZ’s Sean Bohen to exit after business overhaul; report

AZ’s Sean Bohen to exit after business overhaul; report

Pascal Soriot, CEO, AZ. In the end Teva poached Lundbeck CEO Kåre Schultz to fill its top job, but the rumours keep resurfacing with The Times suggesting last November that AZ

Latest news

More from news
Approximately 49 fully matching, plus 113 partially matching documents found.

Latest Intelligence

  • Digital disruption Digital disruption

    R&D, this time within psychiatric and neurological treatments, was in the mind of Lundbeck executives when they signed a drug research deal with IBM Watson Health in February. ... Starting with projects in schizophrenia and Parkinson’s disease,

  • Communiqué Awards 2014 Digital Publication Communiqué Awards 2014 Digital Publication

    See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

  • The Chinese diabetes challenge The Chinese diabetes challenge

    Last month's ChinaBio Partnering Forum in Suzhou, for example, was sponsored by (among others) AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson &Johnson, Lilly, Lundbeck, Novo Nordisk and Roche.

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    825. Chelsea Therapeutics/ Lundbeck. Company acquisition. Includes Northera (droxidopa) for neurogenic orthostatic hypotension (approved).

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    1, 030. Chelsea / Lundbeck. Company acquisition. US company with treatments for rare neurologic diseases.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics